| Name | Title | Contact Details |
|---|
Depression disconnects you from life. TMS Therapy from Salience TMS Neuro Solutions reconnects you. Offices in Dallas-Fort Worth and Houston.
Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The company is focusing on the development of the lead product candidate melflufen, a first-in-class anti-cancer peptide-drug conjugate that rapidly delivers an alkylating payload into tumor cells. Melflufen is in development as a new treatment for the hematological cancer multiple myeloma and is currently being evaluated in multiple clinical studies including the pivotal phase 2 HORIZON study and the ongoing phase 3 OCEAN study. Oncopeptides` headquarters is in Stockholm, Sweden with U.S. headquarters in Boston, Mass. The company is listed in the Mid Cap segment on Nasdaq Stockholm with the ticker ONCO.
Amedra Pharmaceuticals is a Middlesex, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headcan is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hallmark Youthcare is a Residential Treatment Center in Richmond, VA dedicated to treating adolescents with emotional and behavioral mental health issues since 1976.